Erratum to: 'Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial'.
Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK. t.p.hellyer@ncl.ac.uk.
Thomas P
TP
Hellyer
Centre for Population Health Sciences, University of Edinburgh, Medical School, Edinburgh, UK.
Niall H
NH
Anderson
Newcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, UK.
Jennie
J
Parker
Institute of Inflammation and Repair, University of Manchester, Manchester Academic Health Sciences Centre & Intensive Care Unit, Salford Royal NHS Foundation Trust, Greater Manchester, UK.
Paul
P
Dark
Becton Dickinson Biosciences, Erembodegem, Aalst, Belgium.
Tina
T
Van Den Broeck
Intensive Care Unit, Chelsea and Westminster Hospital, Imperial College London, London, UK.
Suveer
S
Singh
Department of Medical Microbiology, Kelvin Building, The Royal Hospitals, Belfast, UK.
Ronan
R
McMullan
Northern Ireland Clinical Trials Unit, Elliot Dynes Building, The Royal Hospitals, Belfast, UK.
Ashley M
AM
Agus
Centre for Experimental Medicine, Queen's University Belfast, Belfast, UK.
Lydia M
LM
Emerson
Centre for Experimental Medicine, Queen's University Belfast, Belfast, UK.
Bronagh
B
Blackwood
Public Health Laboratory, Heart of England NHS Foundation Trust, Birmingham, UK.
Savita
S
Gossain
MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK.
Tim S
TS
Walsh
University of Warwick and Heart of England NHS Foundation Trust, Coventry, UK.
Gavin D
GD
Perkins
Division of Anaesthesia, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, UK.
Andrew Conway
AC
Morris
Centre for Population Health Sciences, University of Edinburgh, Medical School, Edinburgh, UK.|Northern Ireland Clinical Trials Unit, Elliot Dynes Building, The Royal Hospitals, Belfast, UK.|Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, UK.
Daniel F
DF
McAuley
Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
A John
AJ
Simpson
Trials. 2016 Jul 16;17(1):318
27422026